Compare Emerson Electric Co. (EMR) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Emerson Electric Co. vs Stryker Corporation — how do they compare? Emerson Electric Co. trades at $161.83 (market cap $88.72B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is the larger of the two by market cap, and Emerson Electric Co. pays the higher dividend (1.4%). Which is the better fit depends on your goals — on Pluang, investors hold Emerson Electric Co. for 81 Days and Stryker Corporation for 21 Days on average.
| EMR | SYK | |
|---|---|---|
Market Cap | $88.72B | $106.24B |
Volume | 2,355,255 | 2,982,001 |
Sector | Industrials | Health |
52-Week High | $164.38 | $388.35 |
52-Week Low | $123.30 | $269.75 |
Typical Hold Time | 81 Days | 21 Days |
Enterprise Value | $99.80B | $117.70B |
Dividend Yield | 1.4% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Emerson Electric (EMR) trades at $159.06, down slightly by 0.1% today, with a bullish technical signal from moving averages and a consensus price target of $165.90. The company has beaten earnings estimates for the last three quarters, with Q3 2026 EPS expected at $1.84. Revenue grew to $18.02B in 2025, and net income margin improved to 13.83%, supported by strong cash flow from operations of $3.10B.
EMR presents a favorable outlook with analyst buy ratings at 53.49% and projected revenue growth to $18.6B in 2026. Risks include elevated valuation ratios like a P/E of 34.81 and debt-to-asset ratio increase to 31.26 in 2025. The stock's upside is tied to continued earnings beats and operational execution amid industrial sector competition.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
